Heymach J, et al. A phase II trial of poziotinib in EGFR and HER2 exon 20 mutant non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.06.
“Een arts op TikTok bereikt jongeren via hun leefwereld”
apr 2024 | Longoncologie
mrt 2024
nov 2023
sep 2023